DXCM Insider Trading
Insider Ownership Percentage: 0.30%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $9,243,946.62
DexCom Share Price & Price History
Current Price: $66.14
Price Change: ▼ Price Decrease of -1.16 (-1.72%)
As of 04/11/2025 05:00 PM ET
DexCom Insider Trading History
DexCom Institutional Trading History
Data available starting January 2016
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
Read More on DexCom
Today's Range
Now: $66.14
52 Week Range
Now: $66.14
Volume
4,787,867 shs
Average Volume
4,188,339 shs
Market Capitalization
$25.93 billion
P/E Ratio
46.25
Dividend Yield
N/A
Beta
1.5
Who are the company insiders with the largest holdings of DexCom?
DexCom's top insider investors include:
- Kevin R Sayer (CEO)
- Jacob Steven Leach (COO)
- Jacob Steven Leach (EVP)
- Steven Robert Pacelli (Director)
- Jereme M Sylvain (EVP)
- Michael Jon Brown (EVP)
- Jereme M Sylvain (CFO)
- Sadie Stern (EVP)
- Barry J Regan (EVP)
- Steven R Altman (Director)
- Shelly Ramasamy Selvaraj (SVP)
- Paul R Flynn (EVP)
- Matthew Vincent Dolan (EVP)
- Matthew Vincent Dolan (SVP)
- Bridgette P Heller (Director)
Learn More about top insider investors at DexCom.
Who are the major institutional investors of DexCom?
Which major investors are selling DexCom stock?
During the previous quarter, DXCM stock was sold by these institutional investors:
- Congress Asset Management Co.
- E. Ohman J or Asset Management AB
- Sentry Investment Management LLC
- Parallel Advisors LLC
In the previous year, company insiders that have sold DexCom company stock include:
- Kevin R Sayer (CEO)
- Jacob Steven Leach (COO)
- Jacob Steven Leach (EVP)
- Steven Robert Pacelli (Director)
- Jereme M Sylvain (EVP)
- Michael Jon Brown (EVP)
- Jereme M Sylvain (CFO)
- Sadie Stern (EVP)
Learn More investors selling DexCom stock.
Which major investors are buying DexCom stock?
In the last quarter, DXCM stock was acquired by institutional investors including:
- GAMMA Investing LLC
- Fulcrum Capital LLC
- Rhumbline Advisers
- Gradient Investments LLC
- Sendero Wealth Management LLC
- Central Pacific Bank Trust Division
- Czech National Bank
- Portside Wealth Group LLC